SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Medicamen Biotech informs about board meeting

06 Nov 2020 Evaluate

Medicamen Biotech has informed that the meeting of the Board of Directors of the Company is scheduled on 13/11/2020, to consider and approve Un-audited Financial Results (Standalone & Consolidated) for the half year ended on September 30, 2020.

The above information is a part of company’s filings submitted to BSE.

Medicamen Biotech Share Price

258.70 1.60 (0.62%)
24-Apr-2026 12:29 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.50
Dr. Reddys Lab 1321.20
Cipla 1286.45
Zydus Lifesciences 929.70
Lupin 2265.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×